If you have searched Biktarvy price in India, you are probably in one of two situations: a patient in the US facing a cost barrier for one of the most expensive HIV medications on the market — or looking for a straight answer about what the generic manufactured in India actually costs and whether it is legitimate.
This page gives you both. Verified pricing. Honest legal context. Full quality disclosure. And a clear picture of where India-sourced generic Biktarvy fits — and does not fit — into your treatment plan.
The direct answer: Generic Biktarvy (Taffic™) from India generally ranges from $95 to $165 USD per bottle across licensed sources. The US brand-name list price is $4,216 per month.
This is a cluster page within our Biktarvy Generic topic guide. For the full overview, start with the Biktarvy Generic pillar page.
Biktarvy Topic Guide — Related Pages
Table of Contents
Biktarvy Price in India — At a Glance (2026)
What Is Generic Biktarvy Made in India?
The generic version of Biktarvy most widely available from India is called Taffic™, manufactured by Hetero Labs — one of India’s largest pharmaceutical manufacturers. This is not a counterfeit product. It is a legitimately licensed generic, manufactured under explicit authorization from Gilead Sciences.
Active Ingredients — Identical to Brand-Name Biktarvy
| Active Ingredient | Dose | Drug Class | Role in HIV Treatment |
|---|---|---|---|
| Bictegravir | 50 mg | INSTI | Blocks HIV integrase enzyme — prevents viral DNA from inserting into human cells |
| Emtricitabine | 200 mg | NRTI | Inhibits HIV reverse transcriptase, halting viral replication |
| Tenofovir Alafenamide (TAF) | 25 mg | NRTI | Prodrug converted to tenofovir inside cells; lower kidney and bone impact than older TDF formulations |
Taffic™ is manufactured by Hetero Labs under a voluntary licence granted by Gilead Sciences through the Medicines Patent Pool (MPP). Hetero’s manufacturing facilities are certified to US FDA cGMP standards. Taffic™ is also approved by India’s CDSCO — India’s equivalent of the FDA.
Why Is Biktarvy So Much Cheaper When Sourced from India?
1. Voluntary Licensing Removes the Patent Barrier
Gilead Sciences granted voluntary licences to manufacturers like Hetero Labs through the Medicines Patent Pool. These licences allow generic production in designated countries. The manufacturer pays Gilead a royalty and produces the drug at manufacturing cost rather than brand-with-patent pricing.
2. India’s Manufacturing Cost Structure
India is the world’s largest exporter of generic pharmaceuticals. The country has decades of pharmaceutical manufacturing infrastructure, a deep domestic API supply chain, and production economics that result in genuinely lower per-unit manufacturing costs — not lower quality standards.
3. No US Market Cost Overhead
The $4,216 US list price reflects FDA approval costs, US marketing infrastructure, pharmacy benefit manager rebate negotiations, and litigation reserves. Indian generic manufacturers producing under MPP licence carry none of these costs.
US prescription drug prices are, on average, 2.56 times higher than in other developed countries. For HIV medications with licensed generic equivalents in India, the gap is far larger.
— RAND Corporation International Drug Price Comparison Study
Price Comparison: India Generic vs. US Brand
This table focuses on the India generic vs. US list price delta — the core scope of this page. For a full breakdown of US insurance options, co-pay cards, PAP, ADAP, Medicare, and 340B, see our Biktarvy Cost Without Insurance guide.
| Scenario | Monthly Cost (USD) | Annual Cost (USD) | Key Notes |
|---|---|---|---|
| Generic Biktarvy from India (licensed) | $95–$165 | $1,140–$1,980 | Taffic™ by Hetero Labs; prescription required; FDA cGMP; MPP-licensed |
| US brand Biktarvy — list price (WAC) | $4,216 | $50,592 | Gilead Sciences WAC effective January 1, 2026 |
Quality & Safety: What You Should Verify Before Ordering
| Verification Point | What Legitimate Looks Like | Red Flags |
|---|---|---|
| Manufacturer licence | Named MPP voluntary licence from Gilead; manufacturer identity disclosed | No manufacturer named; no licensing basis stated |
| Manufacturing standard | US FDA cGMP, WHO-GMP, or EMA GMP certified facility | No certifications mentioned or verifiable |
| Prescription policy | Valid prescription required, no exceptions | No prescription required — critical warning sign |
| Contact transparency | Real phone number, verifiable address, responsive support | Email only; no phone; no physical address |
Legal Considerations: Importation, Prescriptions & Your Rights
Under US federal law, importing non-FDA-approved drugs is generally illegal. However, the FDA has maintained a long-standing discretionary non-enforcement policy for personal importation when all of the following conditions are met:
- The medication is for personal use only — not for resale
- The supply does not exceed a 3-month quantity
- The medication presents no significant public health risk
- The patient has a valid US prescription
This policy does not create a legal right to import. Source: FDA Personal Importation Policy.
Addressing the Skepticism Directly
“If it’s so cheap, something must be wrong with it.”
The price is low because the cost inputs are genuinely lower — not because quality corners were cut. The patent barrier was removed via voluntary licence. The manufacturing facility is FDA cGMP-certified. The product is CDSCO-approved. Hetero Labs has been supplying generic medicines to global health programs including PEPFAR and WHO procurement for over two decades.
“I’ve seen other sites selling Biktarvy from India for $30.”
Prices far below $95 through international patient-access services likely reflect India domestic wholesale pricing without international shipping and compliance costs — or unverified sources without quality controls. A site quoting $30 with international shipping and no prescription requirement is a serious warning sign.
“My doctor doesn’t know about this. Should I be worried?”
You should absolutely tell your doctor. Your HIV specialist needs to know what medication you are taking and should monitor your viral load whenever there is any change to your treatment supply.
Frequently Asked Questions
How we reviewed this article:
SunnyPharma follows strict sourcing guidelines relying on peer-reviewed research, government agencies (FDA, WHO, CDSCO), primary manufacturer data, and verified market pricing.
Read our editorial policy →Sources & References
- FDA Biktarvy Prescribing Information (2025): accessdata.fda.gov
- Gilead Price Information — Biktarvy WAC (January 2026): gileadpriceinfo.com
- Medicines Patent Pool — Gilead Licensing: medicinespatentpool.org
- FDA — Personal Importation Policy: fda.gov
- RAND Corporation — International Drug Price Comparisons: rand.org
- NASTAD ADAP Watch: nastad.org
- HRSA — Find HIV Care: findhivcare.hrsa.gov
- Gilead Advancing Access: gileadadvancingaccess.com